Protara Therapeutics (1KPA.F) Q4 2024 Earnings

12NovConfirmed
Q2 2024
Q3 2024
Q4 2024
-0.9
-0.74
-0.58
-0.41

Details

Expected EPS
-0.48981399999999997
Actual EPS
-0.470975
Surprise EPS
0.02
Surprise Percent
+3.85%

Description

Protara Therapeutics (1KPA.F) has reported earnings of -0.470975 per share for Q4 2024.

0 Comments

Share your thoughts